TG THERAPEUTICS INC's ticker is and the CUSIP is 88322Q908. A total of 5 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,063,248 | -88.0% | 246,800 | -64.3% | 0.00% | -83.3% |
| Q2 2023 | $17,184,312 | +363.1% | 691,800 | +180.4% | 0.01% | +200.0% |
| Q1 2023 | $3,710,368 | -29.6% | 246,700 | -44.7% | 0.00% | 0.0% |
| Q4 2022 | $5,273,814 | +15.7% | 445,800 | -42.1% | 0.00% | 0.0% |
| Q3 2022 | $4,557,000 | +175.7% | 769,800 | +97.9% | 0.00% | +100.0% |
| Q2 2022 | $1,653,000 | – | 389,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 1,466,300 | $8,681,000 | 0.02% |
| SIMPLEX TRADING, LLC | 492,400 | $2,915,000 | 0.00% |
| JANE STREET GROUP, LLC | 769,800 | $4,557,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 50,000 | $296,000 | 0.00% |